First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
27.99
+0.12 (0.43%)
Feb 21, 2025, 4:00 PM EST - Market closed
FTXH Holdings List
As of Feb 20, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | BMY | Bristol-Myers Squibb Company | 8.53% |
| 2 | ABBV | AbbVie Inc. | 7.81% |
| 3 | JNJ | Johnson & Johnson | 7.35% |
| 4 | PFE | Pfizer Inc. | 6.82% |
| 5 | MRK | Merck & Co., Inc. | 5.65% |
| 6 | GILD | Gilead Sciences, Inc. | 5.32% |
| 7 | CAH | Cardinal Health, Inc. | 4.32% |
| 8 | JAZZ | Jazz Pharmaceuticals plc | 3.82% |
| 9 | UTHR | United Therapeutics Corporation | 3.73% |
| 10 | VTRS | Viatris Inc. | 3.50% |
| 11 | LLY | Eli Lilly and Company | 3.47% |
| 12 | AMGN | Amgen Inc. | 3.41% |
| 13 | ZTS | Zoetis Inc. | 3.28% |
| 14 | BIIB | Biogen Inc. | 2.55% |
| 15 | OGN | Organon & Co. | 2.50% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 2.24% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.05% |
| 18 | MEDP | Medpace Holdings, Inc. | 1.85% |
| 19 | ELAN | Elanco Animal Health Incorporated | 1.46% |
| 20 | ALKS | Alkermes plc | 1.34% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.32% |
| 22 | HALO | Halozyme Therapeutics, Inc. | 1.27% |
| 23 | EXEL | Exelixis, Inc. | 1.13% |
| 24 | PBH | Prestige Consumer Healthcare Inc. | 1.01% |
| 25 | CORT | Corcept Therapeutics Incorporated | 0.98% |
| 26 | ITCI | Intra-Cellular Therapies, Inc. | 0.93% |
| 27 | PRGO | Perrigo Company plc | 0.92% |
| 28 | TGTX | TG Therapeutics, Inc. | 0.70% |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 0.66% |
| 30 | ACAD | ACADIA Pharmaceuticals Inc. | 0.65% |
| 31 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.63% |
| 32 | INSM | Insmed Incorporated | 0.58% |
| 33 | INCY | Incyte Corporation | 0.58% |
| 34 | VCEL | Vericel Corporation | 0.56% |
| 35 | TWST | Twist Bioscience Corporation | 0.55% |
| 36 | BPMC | Blueprint Medicines Corporation | 0.52% |
| 37 | VRTX | Vertex Pharmaceuticals Incorporated | 0.51% |
| 38 | ACLX | Arcellx, Inc. | 0.51% |
| 39 | KRYS | Krystal Biotech, Inc. | 0.50% |
| 40 | ADMA | ADMA Biologics, Inc. | 0.49% |
| 41 | AMRX | Amneal Pharmaceuticals, Inc. | 0.48% |
| 42 | ROIV | Roivant Sciences Ltd. | 0.46% |
| 43 | BMRN | BioMarin Pharmaceutical Inc. | 0.45% |
| 44 | EXAS | Exact Sciences Corporation | 0.43% |
| 45 | SRPT | Sarepta Therapeutics, Inc. | 0.42% |
| 46 | KYMR | Kymera Therapeutics, Inc. | 0.41% |
| 47 | RNA | Avidity Biosciences, Inc. | 0.39% |
| 48 | IONS | Ionis Pharmaceuticals, Inc. | 0.36% |
| 49 | MYGN | Myriad Genetics, Inc. | 0.28% |
| 50 | VKTX | Viking Therapeutics, Inc. | 0.26% |
As of Feb 20, 2025